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Summary: Recurrent event processes describe the stochastic repetition of an event over time. Recurrent event
times are often censored with dependence between the censoring time and recurrence process. For instance, recurrent
disease events are censored by a terminal event such as death, while frailty might affect both disease recurrence and
survival. As such, it is important to model the recurrent event process and the event time process jointly to better
capture the dependency between them and improve interpretability of the results. We propose a model in which the
number of gap times, i.e. the time between two consecutive recurrent events, before the terminal event occurs is a
random variable of interest. Then, conditionally on the number of recurrent events, we specify a joint distribution
for the gap times and the survival time. Dependence between the the recurrence and survival processes is introduced
by specifying a joint distribution on their respective frailty terms. Moreover, an autoregressive model of order one
is assumed to model the evolution of gap times over time. A non-parametric random effects distribution for the
frailty terms accommodates population heterogeneity and allows for data-driven clustering of the subjects. Posterior
inference is performed through a a Gibbs sampler strategy involving a reversible jump step and slice sampling. We
illustrate our model on atrial fibrillation data and compare the performance of our model with existing approaches.
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1. Introduction
Recurrent events arise in many applications including, amongst others, medicine, science and
technology. Examples include recurrent infections, asthma attacks, hospitalizations, product
repairs, and machine failures. This work focuses on settings where recurrent events are
available from a large number of individuals, but with a small number of occurrences for
each subject. Additionally, we are interested in modelling some other time to event such as
death or failure, which is related to the recurrence process. Information on the time to this
event is available for each individual. As in a standard survival event framework, the time
to event can be observed or right-censored. We propose a joint model for the time and the
number of recurrent events, as well as for the terminal event.
Typically, the goal is modelling the rate of occurrence to account for variation within
and between individuals and at the same time to understand how the recurrence process
affects survival. Moreover, the relationship between both event occurrence and survival with
potential explanatory factors is often of interest. An important factor in medical applications
related to recurrent events and survival time is the overall frailty. Increased frailty is often
associated with both increased disease recurrence and reduced survival. Frailty thus induces
dependence between survival time and recurrent events.
The two main statistical approaches to inference on recurrent events are (1) modelling
the intensity or hazard function of the event counts process and (2) modelling the sequence
of times between recurrent events, known as gap times or waiting times (Cook and Law-
less, 2007). The first approach is most suitable when individuals frequently experience the
recurrent event of interest and the occurrence does not alter the process itself. Here, we
mention some examples that consider the dependence between recurrence and survival time.
Liu, Wolfe, and Huang (2004), Rondeau et al. (2007), Ye, Kalbfleisch, and Schaubel (2007),
Huang, Qin, and Wang (2010), Sinha et al. (2008) and Ouyang et al. (2013) model the
2intensity of the recurrent events and the survival time. The latter two approaches propose
Bayesian methods with an emphasis on modelling the risk of death and the risks of rejections
for heart transplantation patients. Olesen and Parner (2006), Huang and Liu (2007), Yu
and Liu (2011), Bao et al. (2012) and Liu et al. (2015) model the hazard function of the
recurrent events and of the survival jointly, with the recurrent events and the survival being
independent conditionally on the frailty parameters. Li, Chinchilli, and Wang (2018, 2019)
use a copula inside a Bayesian hazards model to allow for dependence between recurrence
and survival process conditionally on the frailty parameters. Yu et al. (2013) model the
intensity of the recurrent events and the hazard function of survival jointly while assuming
independent censoring before death.
The second approach, which focuses on the sequence of gap times, is more appropriate when
the recurrent events are relatively infrequent, when individual renewal takes place after an
event, or when the goal is prediction of the time to the next event. This works places itself
within this framework, as the events in our application are infrequent but measured on many
individuals. In this context, Tallarita et al. (2016) and Paulon et al. (2018) propose Bayesian
non-parametric models for the gap times, with the latter also considering dependence with
survival time.
Olesen and Parner (2006), Huang and Liu (2007), and Paulon et al. (2018) consider
censoring by a terminal event such as survival. They assume the existence of a large number
of recurrent events for each individual with the recurrent event process defined also after the
terminal event has occurred. The gap times are censored either by the survival censoring time
or by the survival time. The contribution to the likelihood of the gap times after censoring is
assumed to be equal to one. As a result, the censored gap times do not affect the inference. As
an alternative, we do not assume an arbitrary large number of recurrent events but explicitly
model the number of recurrent events before the terminal event. Then, conditional on the
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number of events, we specify a joint distribution for gap times and survival. This strategy
allows capturing the dependence structure between the recurrence and survival processes,
which is important in medical applications and beyond.
Subject-specific random effects describe the frailty by informing both the survival time
and the dependence of subsequent gap times. The random effects are modelled flexibly with
a Dirichlet process (DP, Ferguson, 1973) prior as in Tallarita et al. (2016) and Paulon et al.
(2018), arguably the most popular non-parametric prior. It is well known that the DP is
almost surely discrete. This feature is particularly useful in applications as it allows for
data-driven clustering of observations. If G is DP(M, G0) with concentration parameter M
and base measure G0, then it admits a stick-breaking representation (Sethuraman, 1994) and





where δθh is a point mass at θh, the weights wh follow the stick-breaking process wh =
Vh
∏
j<h(1− Vj) with Vh i.i.d.∼ Beta(1, M), and the atoms {θh}∞h=1 are such that θh ∼ G0.
The sequences {θh}∞h=1 and {Vh}∞h=1 are independent. The discreteness ofG induces clustering
of the subjects, based on the unique values of the random locations θh, where the number of
clusters is learned from the data. This choice allows for extra flexibility, variability between
individual trajectories, overdispersion and clustering of observations, and overcomes the often
too restrictive assumptions underlying a parametric random effects distribution.
Paulon et al. (2018) specify a single random effects parameter which influences both the
distribution of the gap times and the distribution of survival. Instead, we introduce different
random effects parameters, one for the recurrence process and one for the survival. We
model these jointly using a DP prior, ensuring dependence between recurrence and survival.
Additionally, we specify an autoregressive model for the gap times to capture the dependence
4between subsequent gap times. Tallarita et al. (2016) also use an autoregressive model but
on the random effects instead of the gap times themselves.
The paper is structured as follows. Section 2 introduces the model. Section 3 discusses an
application to atrial fibrillation data. Section 4 compares our approach with existing ones.
Section 5 concludes the paper.
2. Model
2.1 Notation
We consider data on L individuals. Let Ti0 denote the start time of the recurrent event
process for individual i. We assume Ti0 = 0 for i = 1, . . . , L. Let Si denote the survival
time for individual i since the start of the corresponding event process. Each individual i
experiences Ni recurrent events over the time interval (0, Si]. Let Tij denote the jth event
time for individual i. Then, the last event time TiNi is less than or equal to Si. Let ci denote the
minimum of the censoring time and the survival time Si for individual i, who is thus observed
over the interval (0, ci]. Let ni 6 Ni denote the number of events that are observed over the
interval (0, ci]. Either Si or the censoring time is observed. If Si is observed, then Ni = ni and
0 < Ti1 < · · · < TiNi 6 Si = ci. If Si is not observed, then Ni > ni and Si > ci are unknown
and object of inference. In this case, 0 < Ti1 < · · · < Tini 6 ci < Ti(ni+1) < · · · < TiNi 6 Si.
We define the log gap times as
Yij = log(Tij − Ti(j−1)), (1)
for j = 1, . . . , Ni. The q-dimensional vector xi contains individual-specific covariates.
2.2 Likelihood specification
Firstly, we assume that the number of gap times Ni follows a Poisson distribution with
rate parameter λ that is truncated by Ni > 1: Ni ∼ 1[1,∞) Poisson(λ), independently
for i = 1, . . . , L. Conditionally on Ni, we specify a joint model for the log gap times
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Y i = (Yi1, . . . , YiNi)
T and the survival time Si. We define the joint density p(Y i, Si | —) =
p(Y i | Si,—) p(Si | —) by specifying the conditional densities p(Y i | Si,—) and p(Si | —).
We build on existing literature (Tallarita et al., 2016; Paulon et al., 2018) by assuming that
the gap times and survival times follow log-normal distributions where the pairs (Y i, Si)
are mutually independent for i = 1, . . . , L, conditionally on the random effects, number of
recurrent events Ni and the other parameters in the model.
The random effects parameter for the gap times is the two-dimensional vector mi which
characterizes an autoregressive model for Y i:
p(Y i | β,mi, Ni, Si, σ2,xi)
∝ N (Yi1 | xTi β +mi1, σ2)
Ni∏
j=1
N{Yij | xTi β +mi1 +mi2(Yi(j−1) − xTi β −mi1), σ2}, (2)
for TiNi 6 Si, where TiNi =
∑Ni
j=1 e
Yij per (1) and the q-dimensional vector β consists of
covariate effects on the gap times. This resembles the autoregressive model on the random
effects in Tallarita et al. (2016, Equation 2). Two main differences are due to the fact that
the the mean of Yij is the same for all j conditionally on the remaining parameters in our
model and that Tallarita et al. (2016) do not consider a survival process, which implies
the truncation TiNi 6 Si in our work. The truncation results from our conditioning on Ni
whereas existing literature (Aalen and Husebye, 1991; Tallarita et al., 2016; Paulon et al.,
2018) specifies the likelihood as a joint distribution of the number of events ni observed over
the interval (0, ci] and their log gap times Yi1, . . . , Yini .
The distribution of the log survival time is Gaussian as in Paulon et al. (2018):
log(Si) ∼ N (xTi γ + δi, η2), (3)
independently for i = 1, . . . , L, where the q-dimensional vector γ consists of covariate effects
on the survival time and δi denotes a random effects parameter. Covariate effects can differ
between gap and survival times, for instance if a therapy delays disease recurrence but does
6not prolong survival. Therefore, the model on the gap times in (2) and on the survival times
in (3) have distinct regression coefficients β and γ, respectively.
2.3 Prior specification
We specify a non-parametric prior for the random effects parameters mi and δi in (2) and
(3). In more detail, (mi, δi) ∼ G independently for i = 1, . . . , L where G ∼ DP(M, G0), with
M ∼ Gamma(aM , bM) and base measure G0 = N2(02×1, σ2mI2)×N (0, σ2δ ). Finally, the prior
distributions on the remaining parameters are β ∼ Nq(0q×1, σ2β Iq), γ ∼ Nq(0q×1, σ2γ Iq),
σ2 ∼ Inv-Gamma(νσ2/2, νσ2 σ20/2), η2 ∼ Inv-Gamma(νη2/2, νη2 η20/2) and λ ∼ Gamma(aλ, bλ).
2.4 Posterior inference
Posterior inference is performed through a Gibbs sampler algorithm. This includes imputing
Ni, Yi(ni+1), . . . , YiNi and Si for each censored individual i. The Gibbs update for Ni and Y i
is transdimensional since the number of events Ni is the dimensionality of the sequence of log
gap times Y i. This requires devising a reversible jump sampler (Green, 1995) for Ni and Y i.
Most full conditional distributions are intractable due to the truncation TiNi 6 Si, which for
instance causes the normalization constant in (2) to depend on parameters of interest. We
use slice sampling (Neal, 2003) to deal with this intractability. The normalization constant
in (2) is also intractable. We therefore approximate it using the Fenton-Wilkinson method
(Fenton, 1960). Algorithm 8 from Neal (2000) is implemented to sample the DP parameters
(mi, δi). Web Appendix A details and derives the MCMC algorithms.
3. Application to atrial fibrillation data
3.1 Background
We apply our model to the data on atrial fibrillation (AF) described in Schroder et al.
(2019b). AF is the most common serious cardiac arrhythmia with more than 33 million
cases worldwide, increasing rapidly with 5 million new cases per year (Chung et al., 2020). It
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is characterized by an irregular and often high heart rate where the heart’s upper chambers
beat out of sync with its lower chambers. AF causes substantial morbidity and mortality,
for instance due to heart failure and stroke. It places a high burden on health care systems,
constituting 2.4% of the United Kingdom’s National Health Service budget in 2000 (Thrall
et al., 2006).
AF is often a chronic condition that requires repeated treatment. The goal of these treat-
ments is to reduce the rate of AF episodes, as an increased number of episodes is associated
with complications such as stroke (Munger, Wu, and Shen, 2014). Thus, there is dependence
between recurrence and survival, which our model is able to capture. Additionally, more
frequent AF events are associated with an increase in the rate of episodes going forward
(Wijffels et al., 1995). This points to temporal dependence in the AF recurrence process, as
captured in our model by (2).
A variety of treatments exist. These include prophylactic anti-arrhythmic medication and
cardioversion (Schroder et al., 2019b). Anti-arrhythmic medication aims to reduce the rate
and duration of AF episodes. Cardioversion aims to restore the heart rhythm when it is
abnormal, that is while someone is experiencing an AF episode. Cardioversion is either
electrical, using direct currents, or pharmacologic. Electrical cardioversion takes place in a
hospital. AF diagnosis usually requires an electrocardiogram (ECG).
The condition of AF can be categorized into three subtypes: paroxysmal, persistent and
permanent (January et al., 2014). Episodes of paroxysmal AF terminate spontaneously
without treatment. In contrast, persistent AF is when the episode only ends due to an
intervention. Lastly, AF is permanent when the patient and clinician decide to no longer
attempt to restore the heart rhythm. Additionally, AF episodes are either symptomatic or
asymptomatic. Symptoms of AF include palpitations and chest pain.
As for many other chronic diseases, clinical interest lies in both the final outcome (death
8or survival time) and the dynamics of the process itself, since it determines the subsequent
quality of the patient’s life (Thrall et al., 2006). From an economic and healthcare planning
perspective, there is great interest in reducing rehospitalization for AF. In fact, a better
understanding of both death and non-fatal clinical events could lead to improved prognosis
and assessment of the impact and costs of AF by health providers. It is, therefore, of
paramount importance to develop a comprehensive model for disease management, mortality
and associated clinical event histories, which also accounts for the significant inter-individual
variability in disease course as it is typical of chronic diseases and biological events.
3.2 Data description and analysis
The data (Schroder et al., 2019a) consist of hospitalizations from January 1, 2008 to March
1, 2014 at the Department of Cardiology at University Hospital Copenhagen, Hvidovre, Den-
mark (Schroder et al., 2019b). The primary reason of all hospitalizations is symptomatic AF.
Some include cardioversion treatment. AF is confirmed by ECG. We consider L = 60 patients
that experience more than one hospitalization and thus at least one rehospitalization. This
first hospitalization represents the origin of a patient’s recurrence process such that Ti0 = 0
for all i. Consequently, ni represents the number of observed gap times between subsequent
hospitalizations due to AF. Patients experience between 1 and 16 rehospitalizations each and∑L
i=1 ni = 252 in aggregate. Web Table 1 shows how they are distributed across patients.
Gap times are defined as the difference between successive hospitalizations and, as such,
capture both the length of stay in the hospital and the time between discharge and the next
hospitalization.
The main clinical outcome of interest is deterioration to permanent AF or death. We
therefore define the survival time Si as the time to permanent AF or death. If the terminal
event is permanent AF, which is diagnosed during a rehospitalization, then the terminal
event is also the last recurrent event such that Si = TiNi . The survival times of 45 out of the
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60 recurrence processes are censored due to the follow-up ending on March 1, 2014, resulting
in unobserved total number of gap times Ni.
Patient characteristics are determined at the first hospitalization. They are 1) age; and
the binary variables 2) gender; whether 3) AF is paroxysmal or persistent; and whether
the patient has 4) hypertension; 5) heart disease; or 6) is on anti-arrhythmic medication.
Here, heart disease includes heart failure, heart valve disease and ischemic heart disease.
These variables form the subject-specific 6-dimensional covariate vector xi, with q = 6.
Being older or female, hypertension and heart disease are known to be associated with more
severe AF (January et al., 2014). Anti-arrhythmic medication aims to prevent and ameliorate
the reoccurrence of AF. We standardize the age in xi. Table 1, and Web Figures 1 and 2
summarize the patient characteristics, and the gap and survival times.
We choose hyperparameters yielding uninformative prior distributions as detailed in Web
Appendix B. The base measure G0 of the DP prior has high variance. A priori, σ
2 and η2 have
an expected value of one and a variance of 100. Analogously, the regression coefficients β and
γ have high prior variance. We run the Gibbs sampler for 200,000 iterations, discarding the
first 20,000 as burn-in and thinning every 10 iterations, resulting in a final posterior sample
size of 18,000.
3.3 Posterior inference on the number of recurrent events
Figure 1 summarizes the posterior distribution of the total number of gap times Ni for each
patient.
[Figure 1 about here.]
The posterior means for the censored Ni are generally in line with the observed Ni. The
unobserved Ni are sometimes inferred to be larger than the largest observed Ni. After all,
the largest observed Ni equals 8 while the number of observed gap times ni = 16 for one
patient. This is expected since patients with longer survival times Si are both more likely
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to have a higher number of gap times Ni and to be censored. Our model flexibly captures
Ni’s uncertainty, which varies notably across censored patients. These findings highlight the
importance of modelling Ni when the number of events is censored and, therefore, unknown.
3.4 Posterior inference on the regression coefficients
The regression coefficients β and γ capture the covariate effects on the recurrent event and
survival processes, respectively. Figure 2 shows no evident effect of any of the covariates as
the corresponding 95% credible intervals include 0.
[Figure 2 about here.]
This is in line with the analysis of these data described in Schroder et al. (2019b). The
relatively small sample size of L = 60 might be the reason that we do not find strong effects,
even though most of these covariates are risk factors for AF.
3.5 Posterior inference on the cluster allocation
As discussed in Section 1, the DP prior on (mi, δi) described in Section 2.3 allows for
clustering of patients based on their recurrent event and survival profiles. The random
effects parameters determine the clustering of patients and capture the dependence between
the recurrence and survival processes. Indeed, the posterior predictive distribution of these
parameters for a hypothetical new patient is multimodal as shown in Figure 3, indicating
the presence of multiple patient subpopulations.
[Figure 3 about here.]
The clustering depends on both gap time trajectories and survival outcomes thanks to
the joint distribution on mi and δi. In particular, Figure 3 reports the bivariate posterior
marginal of (mi0, δi0) and (mi1, δi), which are clearly trimodal. It is interesting to note that
the modes for mi1 are centred around the same value, indicating a similar time dependence
structure among gap times across clusters.
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Posterior inference on the clustering structure of the patients is of clinical interested as
it might guide more targeted therapies. Our Gibbs sampler provides posterior samples of
the cluster allocation. Here, we report the cluster allocation that minimizes the posterior
expectation of Binder’s loss function (Binder, 1978) under equal misclassification costs, which
is a common choice in the applied Bayesian non-parametrics literature (Lau and Green,
2007). See Argiento, Cremaschi, and Guglielmi (2014, Appendix B) for computational details.
Briefly, Binder’s loss function measures the difference for all possible pairs of individuals
between the true probability of co-clustering and the estimated cluster allocation. In this
context, the posterior estimate of the partition of the patients has 4 clusters, with 92% of
the patients allocated to 2 clusters which are summarized in Table 1.
[Table 1 about here.]
The larger cluster, Cluster 1, has longer gap and survival times than Cluster 2. Moreover,
the Kaplan-Meier curves of each cluster in Figure 4 support the conclusion that Cluster 1
includes patients with longer survival times than Cluster 2.
[Figure 4 about here.]
As shown in Table 1, Cluster 1 has a higher censoring rate than Cluster 2, as one might
expect at longer survival times. The lower prevalence of hypertension and slightly lower age
of Cluster 1 also confirm that it includes healthier subjects than Cluster 2
Web Figures 3 and 4 contain additional posterior results.
4. Comparison with other models
4.1 Cox proportional hazards model
We now compare our results on the AF data to those from the Cox proportional hazards
model which is one of the most popular semi-parametric models in survival analysis with
covariates. In this model, the hazard function for mortality is hi(t | θ) = h0(t) exp(zTi θ)
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where h0(t) is the baseline hazard function, zi is a vector of covariates and θ is a vector
of regression coefficients. Here, a larger value of zTi θ leads to shorter survival times. This
contrasts with (3) from our model where a larger xTi γ is associated with longer survival
times. Our model allows for dependence between the gap and survival times. Therefore, for
a fairer comparison when fitting the Cox proportional hazard model, we include a patient’s
log mean gap time in the covariate vector zi in addition to the 6 covariates included in xi
described in Section 3.2.
Web Table 2 shows the covariate effects on survival from the Cox proportional hazards
model. They agree with those from our model in Figure 2 except for the effect of age. Both
models suggest that a higher age corresponds to shorter survival but this effect is statistically
significant only in the Cox proportional hazards model. The other covariates do not exhibit
a significant effect for both models.
4.2 Joint frailty model
We also compare our model with the joint frailty model by Rondeau et al. (2007) as
implemented in the R package frailtypack (Rondeau, Mazroui, and Gonzalez, 2012). The
model estimates the hazard functions of rehospitalization and mortality jointly using two
patient-specific frailty terms, namely ui and vi. The frailty term ui captures the association
between rehospitalization and mortality while vi appears solely in the rehospitalization rate.
Specifically, the hazard functions are ri(t | ui, vi,β) = ui vi r0(t) exp(xTi β) for rehospital-
ization and λi(t|ui,γ) = ui λ0(t) exp(xTi γ) for mortality. Here, r0(t) and λ0(t) are baseline
hazard functions, and xi, β and γ are defined as in Section 2. The random effects distributions
are specified as follows: vi ∼ Gamma(1/ρ, 1/ρ) and ui ∼ Gamma(1/, 1/) independently
for i = 1, . . . , L.
To fit this model to the AF data, we drop hypertension from xi due to convergence issues
when using all covariates. The comparison between the joint frailty model results in Web
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Table 3 with our results in Figure 2 shows that both models obtain similar results and do
not detect an association for most of the covariates. Exceptions are the effect of age and
use of anti-arrhythmic medication on rehospitalization, and the effects of age and gender on
survival. For these, the joint frailty model finds a statistically significant effect.
Finally, the estimate of ρ is 0.005 with a standard error of 0.0009. This suggests hetero-
geneity between patients that is not explained by the covariates. The estimate of  is 0.032
with a standard error of 0.04. This implies that the rate of rehospitalizations is positively
associated with mortality. These results are in line with the posterior clustering results from
our model in Table 1 where Cluster 1 is characterized by both the longest gap times and the
longest survival times.
4.3 Bayesian semi-parametric model from Paulon et al. (2018)
For a more direct comparison, we consider the method proposed by Paulon et al. (2018) as
it models the gap and survival times jointly using Bayesian non-parametric priors. Paulon
et al. (2018) assume that, conditionally on all parameters and random effects, the gap times
are independent of both each other and the survival time. This contrasts with the temporal
dependence between gap times in (2). Shared random effects induce dependence between
different gap times of the same patient. Specifically, Paulon et al. (2018) assume Yij ∼
N (xTi β + αi, σ2i ) independently for j = 1, . . . , ni + 1 and i = 1, . . . , L, and
log(Si) ∼ N (xTi γ + ψ αi, η2), (4)
independently for i = 1, . . . , L, where xi, β and γ are defined as in Section 2, and αi and σi
are random effects. Paulon et al. (2018) do not model the total number of gap times Ni but
assume that each patient has a censored (ni + 1)th log gap time Yi(ni+1). They also assume
a priori independence among β, γ, ψ, η and (α, σ2). The random effects (αi, σ
2
i ) ∼ G
independently for i = 1 . . . , L where G ∼ DP(M, G0) with M ∼ Uniform(aM , bM) and
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G0 = N (0, α20) × Inv-Gamma(aσ, bσ). The priors on β, γ and η2 are set as in Section 2.3.
Finally, ψ ∼ N (0, ψ20).
In fitting this model to the AF data, we specify the same xi and the same hyperparameters
for the priors on β, γ and η2 as in Section 3.2. Furthermore, we set aM = 0.3, bM = 5, α
2
0 =
100, aσ = 2.01, bσ = 1.01 and ψ
2
0 = 100. This model yields conclusions that are consistent
with those from our model. In particular, the posterior distributions on the coefficients
in Web Figure 5 closely mimic our results in Figure 2. Also, the posterior on ψ in (4)
concentrates between 1.5 and 3.5 per Web Figure 6. This parameter captures the strength of
the relationship between gap and survival times. Thus, the time between hospitalizations and
survival have a positive association. This is consistent with the clustering results obtained
from our model in Table 1. Lastly, the posterior on the number of clusters for this model and
our model vary slightly, with a mode of 4 clusters for our model in Web Figure 4 while Web
Figure 7 has the mode at 3 for the model from Paulon et al. (2018). A reason for this might be
that our model captures dependence between gap and survival times through its clustering,
as seen in Figure 3, in addition to the truncation TiNi 6 Si of (2). In contrast, Paulon et al.
(2018) can capture such dependence using ψ in (4). Also, the temporal dependence among
gap times in our model can affect how patients are clustered.
5. Discussion
We have introduced a joint model on recurrence and survival that explicitly treats the number
of recurrent events Ni before the terminal event as a random variable and object of inference.
The explicit modelling of Ni as well as the specification of a joint distribution for the random
effects of the recurrence and survival processes induces dependence between these processes.
Moreover, temporal dependence among recurrent events is introduced through a first-order
autoregressive process on the gap times. Extension to a more complex temporal structure
is in principle straightforward. The model allows for estimating covariates effects on the
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recurrence and survival processes by introducing appropriate regression terms. Once again,
extension to time-varying covariates is not problematic. The use of a non-parametric prior as
random effects distribution allows for extra flexibility, patient heterogeneity and data-driven
clustering of the patients.
Comparisons with the Cox proportional hazards model, the joint frailty model (Rondeau
et al., 2007) and the Bayesian semi-parametric model from Paulon et al. (2018) yielded
consistent results. Exceptions were some covariate effects which the Cox proportional hazards
model and the joint frailty model detected but our model did not. This discrepancy might be
the result of the fact that these models have fewer parameters and assume a single patient
population while our model detected multiple subpopulations.
Data Availability Statement
The data used in this paper to illustrate our findings are openly available in figshare at
http://doi.org/10.1371/journal.pone.0217983.s001.
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Web Appendix A Gibbs sampler
This appendix describes the Gibbs sampler summarized in Algorithm A1.
A.1 Normalization constant in p(Yi | β,mi, Ni, Si, σ2,xi)
The distribution in (2) is truncated by TiNi ≤ Si such that the right-hand side of (2) is
not normalized. The normalization constant depends on parameters of interest and is thus
Algorithm A1 Gibbs sampler
For each iteration of the Gibbs sampler:
1. For k = 1, . . . , q, update βk and γk by slice sampling with (A5) and (A8).
2. For each censored individual i:
(a) Update Ni and Y
Ni
i(ni+1)
using the reversible jump sampler from Section A.3.
(b) For j = ni + 1, . . . , Ni, sample Yij from (A9) truncated by Ti(ni+1) > ci and
TiNi ≤ Si using the inverse transformation method.
(c) Sample Si from (A6) truncated to Si > max(ci, TiNi) using the inverse transfor-
mation method.
3. Updatemi and δi for i = 1, . . . , L via Algorithm 8 from Neal (2000) using slice sampling
with (A10–A12).
4. Sample M from the distribution in Equation 13 from Escobar and West (1995).
5. Update σ2, η2 and λ by slice sampling with (A13–A15).
1
required to be able to sample from the full conditionals of these parameters. This differs
from previous likelihood specifications with log-normally distributed gap times (Aalen and
Husebye, 1991; Tallarita et al., 2016; Paulon et al., 2018) because p(Yi | β,mi, Ni, Si, σ2,xi)
is conditional the number of events Ni. The conditioning on Ni requires normalizing the
posterior distribution by a constant that depends on some of the parameters.
To derive the normalization constant in (2), note that
p(Yi | β,mi, Ni, Si, σ2,xi) ∝ NNi(Yi | µYi , ΣYi), TiNi ≤ Si, (A1)
where µYi = (x
T
i β + mi1) 1Ni×1 and the Ni × Ni matrix ΣYi is defined by its tridiagonal






2 for j = 1, . . . , Ni − 1, (Σ−1Yi )NiNi = 1/σ2 and
(Σ−1Yi )j1j2 = −mi2/σ2 for |j1 − j2| = 1.1 Consider now the untruncated Y ∗i ∼ NNi(µYi , ΣYi)
and define T ∗iNi =
∑Ni
j=1 e
Y ∗ij . Then, the normalization constant in (2) equals Pr(T ∗iNi ≤ Si)
where we drop the conditioning on β,mi, Ni, Si and σ
2 for notational convenience. T ∗iNi is the
sum of log-normal random variables. The distribution of such sums and Pr(T ∗iNi ≤ Si) have
no closed-form expression (Asmussen et al., 2019), requiring us to resort to approximations.
It is infeasible to evaluate Pr(T ∗iNi ≤ Si) by numerical integration using quadrature for
the values of Ni that we encounter. Fortunately, there is a literature on approximating
Pr(T ∗iNi ≤ Si) (Botev et al., 2019, and references therein) which includes deterministic and
Monte Carlo methods. As we aim to sample from the full conditionals of β, mi, Ni, Si and
σ2 as part of a Gibbs sampler, we need to evaluate the normalization constant Pr(T ∗iNi ≤ Si)
many times, requiring a fast approximation. We therefore choose the Fenton-Wilkinson
method (Fenton, 1960) which approximates the distribution of T ∗iNi by a log-normal distribu-
tion with matched mean and variance. Asmussen et al. (2019) state that this approximation
can be inaccurate for small Ni and when the elements in Y
∗
i are dependent. However, their
numerical results indicate good performance of the Fenton-Wilkinson method under these
circumstances. Other fast approximations such as the saddle-point method from Asmussen
et al. (2016) might be much more accurate, though they are also more complex than the
Fenton-Wilkinson method.
For any matrix A, denote the elementwise exponential by eA. Define diag(ΣYi) =




i ) = eµYi+diag(ΣYi )/2 = ex
T
i β+mi1 ediag(ΣYi )/2,
Cov(eY
∗
i ) = E(eY
∗
i )2⊗ ◦ (eΣYi − 1Ni×Ni) = e2(x
T
i β+mi1) {ediag(ΣYi )/2}2⊗ ◦ (eΣYi − 1Ni×Ni);
where ‘◦’ denotes the Hadamard product (Halliwell, 2015). Since T ∗iNi = 11×Ni eY
∗
i ,
E(T ∗iNi) = 11×Ni E(e
Y ∗i ) = ex
T
i β+mi1 sum{ediag(ΣYi )/2},
Var(T ∗iNi) = 11×Ni Cov(e
Y ∗i ) 1Ni×1
= e2(x
T
i β+mi1) sum[{ediag(ΣYi )/2}2⊗ ◦ (eΣYi − 1Ni×Ni)];
(A2)
1This implies (ΣYi)j1j2 = (m
|j1−j2|
i2 −mj1+j2i2 )/(1−m2i2) for j1, j2 = 1, . . . , Ni.
2
where sum(·) denotes the grand sum of a matrix which is the sum of all its elements. The
Fenton-Wilkinson approximation to the distribution of T ∗iNi is a log-normal distribution with
the same mean and variance. Let Tˆ ∗iNi be distributed according to this log-normal distribu-



















where the second equality follows from (A2) and sum{ediag(ΣYi )/2}2 = sum[{ediag(ΣYi )/2}2⊗],
and LS1 = log[sum{ediag(ΣYi )/2}] and LS2 = log(sum[{ediag(ΣYi )/2}2⊗ ◦ eΣYi ]) are introduced
for notational convenience. Our approximation to the normalization constant is thus
Pr(T ∗iNi ≤ Si) ≈ Pr{log(Tˆ ∗iNi) ≤ log(Si)} = Φ
[





log(Si)− xTi β −mi1 − 2 LS1 + LS2/2√
LS2 − 2 LS1
}
,
where Φ(·) is the cumulative density function of N (0, 1) and the second equality follows
from (A2). In the remainder of this appendix, we write Pr(T ∗iNi ≤ Si) even though we use
this approximation.
LS1 and LS2 only depend on ΣYi . Therefore, we only need to recompute LS1 and LS2 in
the Gibbs sampler when ΣYi , which is a function of mi2, σ
2 and Ni, changes.
A.2 Regression coefficients
The full conditional for β follows from the prior and the likelihood in Section 2.2 as
p(β |—) ∝ Nq(β | 0, σ2βIq)
L∏
i=1
p(Yi | β,mi, Ni, Si, σ2,xi). (A3)
We can use the expression for p(Yi | β,mi, Ni, Si, σ2,xi) in (2) or (A1) directly to evaluate
(A4), but that is computationally expensive as it involves a multitude of Gaussian density
evaluations. Instead, we introduce Y βi1 = Yi1−mi1, Y βij = {Yij−mi1−mi2(Yi(j−1)−mi1)}/(1−
mi2) for j = 2, . . . , Ni and the Ni × Ni diagonal matrix Σβ,i with diag(Σβ,i) = σ2 {1, (1 −
mi2)
−2, . . . , (1−mi2)−2}T . Then, we can rewrite (2) as
p(Yi | β,mi, Ni, Si, σ2,xi) ∝ NNi(Y βi | 1Ni×1 xTi β, Σβ,i), TiNi ≤ Si.
Inserting this expression into (A3) yields a normal-normal model such that




























sum(Σ−1β,i) = {1 + (Ni − 1)(1 − mi2)2}/σ2. Recalling the conditional distributions of a
multivariate normal, we obtain
p(βk |—) ∝














−k,−k{β−k − (µ∗β)−k} and
Σ∗βk = (Σ
∗
β)kk − (Σ∗β)k,−k(Σ∗β)−1−k,−k(Σ∗β)Tk,−k with the 1 × (q − 1) row vector (Σ∗β)k,−k equal
to the kth row of Σ∗β without its kth element, the (q − 1)× (q − 1) matrix (Σ∗β)−k,−k equal
to Σ∗β without its kth row and kth column, and a−k equal to the vector a without its kth
element, for k = 1, . . . , q. Now, the Gibbs update for β follows as slice sampling with (A5)
as target density for k = 1, . . . , q.
For the other regression coefficient γ, consider that Si ≥ TiNi . Therefore, (3) yields
Pr(Si ≥ TiNi |—) = Φ[{xTi γ + δi − log(TiNi)}/η] and thus
p{log(Si) |—} = N{log(Si) | x
T
i γ + δi, η
2}
Φ[{xTi γ + δi − log(TiNi)}/η]
, Si ≥ TiNi . (A6)
The full conditional for γ then follows with the prior γ ∼ Nq(0, σ2γ Iq) from Section 2.3 as




Nq(γ | µ∗γ , Σ∗γ)∏L
i=1 Φ[{xTi γ + δi − log(TiNi)}/η]
(A7)
where µ∗γ = Σ
∗
γX
T (U − δ)/η2 and Σ∗γ = (Iq/σ2γ + XTX/η2)−1 with the L × q matrix
X = (x1, . . . ,xL)
T and the L-dimensional vector U = {log(S1), . . . , log(SL)}T . Analogously
to (A5), we obtain
p(γk |—) ∝
N (γk | µ∗γk , Σ∗γk)∏L
i=1 Φ[{xTi γ + δi − log(TiNi)}/η]
, (A8)








−k,−k{γ−k − (µ∗γ)−k} and
Σ∗γk = (Σ
∗
γ)kk − (Σ∗γ)k,−k(Σ∗γ)−1−k,−k(Σ∗γ)Tk,−k. Similarly to β, the Gibbs update for γ follows
as slice sampling with (A8) as target density for k = 1, . . . , q.
A.3 Reversible jump sampler for Ni
If individual i is censored, then the number of events Ni is unknown and object of inference.
Since Ni affects the dimensionality of Yi, we use a reversible jump sampler (Green, 1995;




(Yi(ni+1), . . . , YiNi)
T jointly. It is a Metropolis-Hastings algorithm on a state space of varying
dimension. The state space is
⋃∞
Ni=ni
RNi−ni in our case.
4
The proposal distribution for Ni and Y
Ni
i(ni+1)
is as follows. Since Ni ≥ ni, we sample
Ni ∼ 1[ni,∞) Poisson(λ) using the inverse transformation method. To complete the joint
proposal, we only need to specify the proposal distribution of Y Nii(ni+1) given Ni. We use
Tini+1 ∼ U(ci, Si) and Tij | Tij−1 ∼ U(Tij−1, Si) for j = ni + 2, . . . , Ni as TiNi ≤ Si.
We prefer this proposal over sampling along the lines of (2) as then the proposal density
would involve an intractable normalization constant similarly to (2). Instead, we now have
Pr(Tini+1 ≤ t) = (t − ci)/(Si − ci) and Pr(Tij ≤ t | Tij−1) = (t − Tij−1)/(Si − Tij−1) for
j = ni + 2, . . . , Ni. Inserting (1) shows Pr(Yi(ni+1) ≤ y) = (ey + Tini − ci)/(Si − ci) and












Si−Tij−1 , Ni > ni
1, Ni = ni
.
To derive the acceptance probability, we follow the notation in Waagepetersen and
Sorensen (2001, Section 4) where proposed values are denoted by a prime (’). Specifi-








) ∝ Poisson(Ni | λ)




N{Yij | xTi β +mi1 +mi2(Yi(j−1) − xTi β −mi1), σ2},
for Ni ≥ ni, Ti(ni+1) > ci and TiNi ≤ Si. The dimension changing map can be written in the
notation of Waagepetersen and Sorensen (2001, Section 4) as















where g1NiN ′i{Y Nii(ni+1), (Y ′)
N ′i
i(ni+1)
} = (Y ′)N ′ii(ni+1) and g2NiN ′i{Y Nii(ni+1), (Y ′)
N ′i
i(ni+1)
} = Y Nii(ni+1).
The acceptance probability is then given by (Waagepetersen and Sorensen, 2001, Equa-
tion 19)















where |JgNiN′i | denotes the determinant of the Jacobian of gNiN ′i . The elements of JgNiN′i are
all zero except for one entry in each row that equals one so that its determinant equals one.
5
Additionally substituting the definitions of the various terms yields as acceptance probability


























N{Yij | xTi β +mi1 +mi2(Yi(j−1) − xTi β −mi1), σ2}
Pr{log(Tˆ ∗iNi) ≤ log(Si)}
.
This reversible jump sampler updates both Ni and Y
Ni
i(ni+1)
. Additionally, we update
Y Nii(ni+1) as described in the next section to improve mixing of the Gibbs sampler in case the
Metropolis-Hastings sampler in this section rarely accepts the proposed samples.
A.4 Survival and log gap times
If individual i is censored, then the log gap times Y Nii(ni+1) and the survival time Si are imputed
in the Gibbs sampler. The full conditional for the vector Y Nii(ni+1) is hard to sample from due
to the truncation TiNi ≤ Si. Instead, we consider its elementwise full conditionals. By (2),
for j = 2, . . . , Ni − 1,
p(Yij |—) ∝ N
{
Yij





p(YiNi |—) ∝ N{YiNi | xTi β +mi1 +mi2(Yi(Ni−1) − xTi β −mi1), σ2};
(A9)
for Ti(ni+1) > ci and TiNi ≤ Si. Let Rij = Si − TiNi + eYij = Si −
∑
j∗ 6=j e
Yij∗ . Then, eYij is
bounded from above by Rij since TiNi ≤ Si. Additionally, eYi(ni+1) is bounded from below by
ci − Tini since Ti(ni+1) > ci. Therefore, we can sample from (A9) with these truncations for
j = ni + 1, . . . , Ni using the inverse transform method.
We sample Si from (A6) truncated to Si > ci using the inverse transform method.
A.5 Dirichlet process parameters
As detailed in Section 1, the discreteness of the DP induces clustering of the individuals.
Denote the random effects in the hth cluster by (m∗h, δ
∗
h) and the cluster that individual




h). To update (mi, δi)
for i = 1, . . . , L, we update the cluster allocations si and the cluster-specific parameters
(m∗h, δ
∗
h), using Algorithm 8 from Neal (2000) with the algorithm-specific parameter m =
2. We choose this algorithm since independent sampling from the full conditional of m∗h,
required for instance for Neal’s Algorithm 2, is hard due to the intractability of the likelihood
discussed in Section A.1.
6
Neal’s Algorithm 8 requires sampling of (m∗h, δ
∗
h) that leaves its full conditional dis-
tribution invariant. We do this by first sampling m∗h1, then m
∗
h2 and lastly δ
∗
h such that
their respective full conditionals remain invariant. A derivation analogous to the one for
(A4) yields the full conditional for m∗h1. Specifically, we introduce Y
mi1
i1 = Yi1 − xTi β,
Y mi1ij = {Yij − xTi β − mi2(Yi(j−1) − xTi β)}/(1 − mi2) for j = 2, . . . , Ni and the Ni × Ni
diagonal matrix Σmi1 with diag(Σmi1) = σ
2 {1, (1−mi2)−2, . . . , (1−mi2)−2}T . Then,
p(m∗h1 |—) ∝




≤ Si) , (A10)
















with sum(Σ−1mi1) = {1 + (Ni − 1)(1−mi2)2}/σ2.
Similarly for m∗h2, we introduce Y
mi2
i(j−1) = (Yij − xTi β − mi1)/(Yi(j−1) − xTi β − mi1) for
j = 2, . . . , Ni and the (Ni − 1) × (Ni − 1) diagonal matrix Σmi2 with (Σmi2)jj = σ2/(Yij −
xTi β −mi1)2 for j = 1, . . . , Ni − 1. Then,
p(m∗h2 |—) ∝




≤ Si) , (A11)


















j=1 (Yij − xTi β −mi1)2/σ2.
For δ∗h, a derivation similar to the one for (A7) yields
p(δ∗h |—) ∝
N (δ∗h | µ∗δ∗h , Σ∗δ∗h)∏
{i|si=h}Φ[{xTi γ + δ∗h − log(TiNi)}/η]
(A12)




{i|si=h}{log(Si) − xTi γ}/η2 and Σ∗δ∗h = 1/(1/σ2δ + |{i | si = h}|/η2).
Now, the update of (m∗h, δ
∗
h) follows as slice sampling with (A10–A12) as target density for
h = 1, . . . , K where K is the number of clusters.
Equation 13 from Escobar and West (1995) provides the Gibbs update for the DP
concentration parameter M : First, draw ηM ∼ Beta(M + 1, L). Then, with probability
1/[1+L {bM−log(ηM)}/(aM +K−1)] where L denotes the number of individuals, draw M ∼
Gamma{aM +K, bM− log(ηM)}. Otherwise, draw M ∼ Gamma{aM +K−1, bM− log(ηM)}.
A.6 Variance parameters and λ
Recalling the prior and likelihood for σ2 from Section 2.3 and (2), respectively, we obtain
p(σ2 |—) ∝ Inv-Gamma{σ























i β +mi1 +mi2(Yi(j−1) − xTi β −mi1) for j = 2, . . . , Ni.
Similarly for η2, its prior from Section 2.3 and the likelihood in (A6) yield
p(η2 |—) ∝ Inv-Gamma{η
2 | (νη2 + L)/2, (νη2 η20 +
∑L
i=1{log(Si)− xTi γ − δi}2)/2}∏L
i=1 Φ[{xTi γ + δi − log(TiNi)}/η]
.
(A14)
Now, the Gibbs updates for σ2 and η2 follow as slice sampling with (A13) and (A14) as
target density, respectively.
Since Ni ∼ 1[1,∞) Poisson(λ) per Section 2.2, Pr(Ni = l | λ) = Poisson(l | λ)/(1−e−λ) for
l = 1, 2, . . . , where Poisson(· | λ) is the probability mass function of a Poisson distribution
with mean λ and the division by 1−e−λ = 1−Poisson(0 | λ) ensures∑∞l=1 Pr(Ni = l | λ) = 1.
Combining this likelihood with the prior λ ∼ Gamma(aλ, bλ) from Section 2.3 results in
p(λ |—) ∝ Gamma(λ | aλ +
∑L
i=1Ni, bλ + L)
(1− e−λ)L . (A15)
The Gibbs update for λ follows as slice sampling with (A15) as target density.
Web Appendix B Prior specification
For the application of our model to the AF data in Section 3, the hyperparameters of the
prior distributions in Section 2.3 are chosen as follows. The hyperparameters of the priors





































(ν2 − 2)2 (ν2 − 4) = 100;
yields ν1 = 4.02, σ
2
0 = 2.02/4.02, ν2 = 4.02 and η
2
0 = 2.02/4.02. Similarly, the prior
variance of the elements of the regression coefficients β and γ equals σ2β = σ
2
γ = 100.
The hyperparameters related to the base measure G0 of the DP prior are chosen as non-
informative with σ2δ = σ
2
m = 100. We choose an uninformative prior on the DP concentration
parameter M with aM = 2 and bM = 1. Finally, aλ = bλ = 1 specifies the prior for λ.
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Web Table 1: Frequency table of the number of observed gap times ni in the AF data.
ni 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Frequency 14 10 9 4 3 8 4 3 0 2 1 0 1 0 0 1
Web Table 2: Regression coefficients from the Cox proportional hazards model fit on the AF
data.
Covariate Hazard ratio 95% CI
Age 1.90 (1.05, 3.46)
Female 1.60 (0.49, 5.20)
Paroxysmal AF 1.47 (0.19, 11.2)
Hypertension 2.22 (0.62, 7.92)
Heart disease 1.09 (0.25, 4.70)
Antiarrhythmic medication 0.66 (0.13, 3.34)
Log mean gap time 1.09 (0.70, 1.70)
Web Table 3: Regression coefficients from the joint frailty model fit on the AF data.
Rehospitalization
Covariate Hazard ratio p-value
Age 1.02 0.001
Female 0.95 0.71
Paroxysmal AF 0.76 0.40
Heart disease 1.04 0.82
Antiarrhythmic medication 0.63 0.02
Mortality
Covariate Hazard ratio p-value
Age 1.28 0.02
Female 71.1 0.03
Paroxysmal AF 0.19 0.32
Heart disease 3.95 0.19



































Web Figure 2: Histograms of the log of the 15 observed survival times Si (left) and the 45
censoring times in the AF data. If the survival time Si is observed, then ci = Si.
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Web Figure 3: Posterior densities for σ2, η2 and λ from our model fit on the AF data.





















































































Web Figure 5: Posterior means (dot) and 95% marginal posterior credible intervals (lines)
of the regression coefficients from the model in Paulon et al. (2018) fitted on the AF data.
The solid lines represent credible intervals for the regression coefficients β in the gap times
model, while the dashed lines corresponds to the regression coefficients γ in (4) for the
survival times.
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Web Figure 6: Posterior density for ψ in (4) from the model in Paulon et al. (2018) fitted
on the AF data.

















Web Figure 7: Posterior distribution of the number of clusters from the model from Paulon

































































Figure 1. Posterior means (dot or circle) and, if applicable, 95% posterior credible intervals
(solid lines) of the number of gap times Ni for each patient from our model fit on the AF
data. Ni for uncensored patients are represented by a circle and have no credible intervals
since in this case Ni = ni. For censored patients, the number of observed gap times ni is
marked by ‘×’.

































































Figure 2. Posterior means (dot) and 95% marginal posterior credible intervals (lines) of the
regression coefficients from our model fit on the AF data. The solid lines represent credible
intervals for the regression coefficients β in (2) for the gap times model, while the dashed





















Figure 3. Contour plots of the log of the bivariate posterior predictive densities of (mi1, δi)
(left) and (mi2, δi) (right) for a hypothetical new patient from the AF data.
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Figure 4. Kaplan-Meier survival estimates for the two largest clusters estimated minimiz-
ing the expectation of Binder’s loss function (Binder, 1978) under the posterior from our
model on the AF data. The solid and dashed lines represent Cluster 1 and 2, respectively.
The curves are based on the posterior means of log(Si).
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Table 1
Summary statistics for the AF dataset and the posterior estimates from our model. The two clusters are from a
posterior estimate of the cluster allocation that minimizes the posterior expectation of Binder’s loss function
(Binder, 1978). The averages and standard deviations of posterior means are taken across patients and recurrent
events. Si is recorded in days and Yij in log days.
AF dataset Cluster 1 Cluster 2
Number of patients 60 44 11
Proportion censored 75% 95% 0%
Average uncensored Ni 2.60 (2.20) 2.00 (0.00) 2.82 (2.52)
Average posterior mean of Ni (SD) 4.76 (3.08) 5.50 (3.06) 2.82 (2.52)
Average uncensored Yij (SD) 4.18 (1.60) 4.09 (1.60) 4.30 (1.51)
Average posterior mean of Yij (SD) 4.68 (1.42) 4.68 (1.44) 4.30 (1.51)
Average uncensored log(Si) (SD) 5.82 (1.23) 6.76 (0.25) 5.52 (1.30)
Average posterior mean of log(Si) (SD) 14.4 (6.15) 17.1 (4.50) 5.52 (1.30)
Average age (SD) 58.2 (11.4) 56.3 (11.8) 62.4 (7.26)
Proportion female 30% 32% 36%
Proportion with paroxysmal AF 7% 7% 9%
Proportion with hypertension 48% 45% 73%
Proportion with heart disease 20% 20% 18%
Proportion on anti-arrhythmic medication 15 % 14% 9%
